nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—MLNR—nervous system—attention deficit hyperactivity disorder	0.0329	0.389	CbGeAlD
Erythromycin—SLC22A7—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.0282	0.0308	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0279	0.0305	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0274	0.0299	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0272	0.0297	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0239	0.0262	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0235	0.0256	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.019	0.0207	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0182	0.0199	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0179	0.0195	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0166	0.0181	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0163	0.0178	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0154	0.0168	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0154	0.0168	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0149	0.0163	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0147	0.016	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0145	0.0158	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.0142	0.0155	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0139	0.0152	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.0135	0.0148	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0132	0.0144	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.0128	0.014	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0126	0.0137	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0124	0.0136	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0124	0.0135	CbGpPWpGaD
Erythromycin—MLNR—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.0122	0.0134	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0116	0.0126	CbGpPWpGaD
Erythromycin—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.0115	0.0126	CbGpPWpGaD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.0113	0.0123	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.0109	0.012	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.0108	0.0118	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0103	0.0113	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0101	0.011	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0101	0.011	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00974	0.0106	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00958	0.0105	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00946	0.0103	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00946	0.0103	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00935	0.0102	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00916	0.01	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00881	0.00963	CbGpPWpGaD
Erythromycin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00862	0.00942	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00841	0.00918	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00824	0.009	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.0081	0.00885	CbGpPWpGaD
Erythromycin—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.0072	0.00786	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.007	0.00764	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00643	0.00703	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00635	0.00694	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00617	0.00674	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00611	0.00668	CbGpPWpGaD
Erythromycin—SLCO1A2—forebrain—attention deficit hyperactivity disorder	0.00606	0.0714	CbGeAlD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00572	0.00625	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00568	0.00621	CbGpPWpGaD
Erythromycin—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00555	0.00607	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00555	0.00607	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00553	0.00604	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00551	0.00602	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00546	0.00597	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00541	0.00592	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00541	0.00591	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00534	0.00584	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00531	0.0058	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00516	0.00564	CbGpPWpGaD
Erythromycin—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00508	0.00555	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.005	0.00546	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00498	0.00544	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00491	0.00537	CbGpPWpGaD
Erythromycin—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00488	0.00533	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00485	0.0053	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00452	0.00494	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00427	0.00467	CbGpPWpGaD
Erythromycin—SLC22A7—brain—attention deficit hyperactivity disorder	0.00415	0.049	CbGeAlD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00407	0.00445	CbGpPWpGaD
Erythromycin—SLCO1A2—midbrain—attention deficit hyperactivity disorder	0.004	0.0472	CbGeAlD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00392	0.00428	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00384	0.0042	CbGpPWpGaD
Erythromycin—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00376	0.0041	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00375	0.0041	CbGpPWpGaD
Erythromycin—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00367	0.00401	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00367	0.00401	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00349	0.00381	CbGpPWpGaD
Erythromycin—SLCO1A2—nervous system—attention deficit hyperactivity disorder	0.00329	0.0388	CbGeAlD
Erythromycin—MLNR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00328	0.00358	CbGpPWpGaD
Erythromycin—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.00321	0.0378	CbGeAlD
Erythromycin—MLNR—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00317	0.00346	CbGpPWpGaD
Erythromycin—SLCO1A2—central nervous system—attention deficit hyperactivity disorder	0.00316	0.0373	CbGeAlD
Erythromycin—SLCO1A2—cerebellum—attention deficit hyperactivity disorder	0.00309	0.0365	CbGeAlD
Erythromycin—MLNR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00305	0.00333	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00295	0.00323	CbGpPWpGaD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00292	0.0032	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.0029	0.00317	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00287	0.00313	CbGpPWpGaD
Erythromycin—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00272	0.00297	CbGpPWpGaD
Erythromycin—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.0027	0.00295	CbGpPWpGaD
Erythromycin—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00268	0.00293	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00267	0.00292	CbGpPWpGaD
Erythromycin—ABCC1—cerebellum—attention deficit hyperactivity disorder	0.00254	0.0299	CbGeAlD
Erythromycin—SLCO1A2—brain—attention deficit hyperactivity disorder	0.00251	0.0296	CbGeAlD
Erythromycin—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00221	0.00242	CbGpPWpGaD
Erythromycin—ABCC1—brain—attention deficit hyperactivity disorder	0.00206	0.0243	CbGeAlD
Erythromycin—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.00206	0.0243	CbGeAlD
Erythromycin—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00203	0.0239	CbGeAlD
Erythromycin—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00202	0.00221	CbGpPWpGaD
Erythromycin—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00201	0.0022	CbGpPWpGaD
Erythromycin—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00199	0.00218	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00199	0.00218	CbGpPWpGaD
Erythromycin—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.00198	0.0234	CbGeAlD
Erythromycin—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00198	0.00216	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00196	0.00215	CbGpPWpGaD
Erythromycin—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00195	0.00213	CbGpPWpGaD
Erythromycin—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00194	0.00212	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00187	0.00204	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00183	0.002	CbGpPWpGaD
Erythromycin—ABCC1—Disease—STUB1—attention deficit hyperactivity disorder	0.00177	0.00193	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00174	0.00191	CbGpPWpGaD
Erythromycin—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00172	0.0202	CbGeAlD
Erythromycin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00171	0.00186	CbGpPWpGaD
Erythromycin—CYP2B6—brain—attention deficit hyperactivity disorder	0.00157	0.0186	CbGeAlD
Erythromycin—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00156	0.0183	CbGeAlD
Erythromycin—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.0015	0.0177	CbGeAlD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00149	0.00162	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00146	0.00159	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00146	0.00159	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00142	0.00155	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00137	0.00149	CbGpPWpGaD
Erythromycin—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00134	0.0158	CbGeAlD
Erythromycin—ABCC1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00134	0.00146	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00131	0.00143	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00127	0.00139	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00118	0.00129	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00117	0.00128	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00117	0.00127	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00111	0.00121	CbGpPWpGaD
Erythromycin—ABCB1—nervous system—attention deficit hyperactivity disorder	0.0011	0.013	CbGeAlD
Erythromycin—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00106	0.0125	CbGeAlD
Erythromycin—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00104	0.0122	CbGeAlD
Erythromycin—MLNR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000991	0.00108	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000977	0.00107	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000977	0.00107	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000961	0.00105	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000913	0.000997	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000906	0.00099	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0009	0.000984	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000894	0.000976	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000879	0.000961	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000879	0.000961	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000865	0.000945	CbGpPWpGaD
Erythromycin—ABCB1—brain—attention deficit hyperactivity disorder	0.000842	0.00993	CbGeAlD
Erythromycin—ABCC1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000839	0.000917	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000822	0.000898	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000804	0.000879	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000803	0.000877	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000781	0.000853	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000767	0.000838	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000767	0.000838	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000754	0.000824	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000744	0.000812	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000703	0.000768	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000701	0.000766	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000669	0.000731	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000636	0.000695	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000613	0.00067	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000606	0.000662	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000592	0.000647	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000588	0.000642	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000584	0.000638	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000584	0.000638	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00057	0.000623	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000567	0.00062	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000567	0.00062	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000558	0.00061	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000554	0.000606	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000554	0.000606	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000545	0.000596	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000533	0.000582	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000529	0.000578	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000519	0.000567	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000513	0.00056	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000507	0.000554	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000484	0.000529	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000465	0.000508	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000461	0.000504	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000453	0.000495	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000443	0.000484	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000432	0.000472	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000422	0.000461	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000418	0.000457	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000418	0.000457	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000411	0.00045	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000383	0.000418	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000373	0.000408	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000344	0.000375	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000341	0.000373	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000336	0.000367	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000334	0.000365	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000334	0.000365	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000334	0.000365	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000333	0.000364	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000328	0.000359	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000318	0.000348	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000305	0.000334	CbGpPWpGaD
Erythromycin—ABCC1—Disease—EP300—attention deficit hyperactivity disorder	0.000273	0.000298	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000267	0.000292	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000258	0.000282	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000258	0.000282	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000254	0.000278	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000254	0.000277	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000254	0.000277	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000253	0.000277	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000252	0.000275	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000236	0.000258	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000228	0.00025	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000206	0.000225	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000202	0.000221	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000201	0.000219	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	0.000199	0.000218	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000196	0.000214	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000195	0.000213	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000156	0.000171	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000155	0.000169	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000147	0.000161	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	0.000144	0.000157	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000109	0.000119	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	8.67e-05	9.48e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	6.69e-05	7.32e-05	CbGpPWpGaD
